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Potentiation of [Ca2]i response to angiotensin III by cAMP this segment showed that the Ca2 responses to angioten-
in cortical thick ascending limb. sin II (Ang II) and angiotensin III (Ang III) are mediated
Background. In the rat cortical thick ascending limb (CTAL), by the same angiotensin II subtype 1A receptor, AT1A-Rintracellular Ca2 ([Ca2]i) responses to angiotensin II (Ang [1], which is predominantly expressed in this segmentII) and angiotensin III (Ang III) were mediated by the Ang
[2]. The CTAL is characterized by the presence of oneII subtype 1A receptor (AT1A-R), whereas the arginine vaso-
pressin (AVP)-dependent cAMP accumulation involved the morphologic cell type sensitive at least to five different
vasopressin receptor type 2 (V2-R). This work was performed hormones that induce a rise in intracellular cAMP accu-
in CTAL to investigate the crosstalk between these two recep- mulation: arginine vasopressin (AVP), glucagon, calcito-tors by studying their transduction pathways.
nin, parathyroid hormone and -adrenergic agonists [3].Methods. The cAMP-dependent pathway was activated by
Both binding experiments and molecular analysis have10 minutes of prestimulation with either forskolin, CTP-cAMP
or AVP, and Ang II/Ang III-induced [Ca2]i responses were established that vasopressin type 2 receptors (V2-R) but
assessed. not type 1 receptors (V1-R) are present in the rat CTAL
Results. Pretreatment with 5 mol/L forskolin significantly [4, 5]. Classically, stimulation of AT1A-R by Ang II orenhanced the [Ca2]i response induced by 107 mol/L either
Ang III activates phospholipase C (PLC) and inducesAng II or Ang III. Analysis of dose-response curves to Ang
an increase in intracellular Ca2 ([Ca2]i) through phos-III in forskolin-treated CTAL demonstrated that the maximal
[Ca2]i response was significantly increased without altering phatidyl inositol hydrolysis [6] and stimulation by AVP
the EC50. In Ca2-free medium, the forskolin-induced potentia- of V2-R coupled to adenylyl cyclase (AC) activatestion of the [Ca2]i response to Ang III was weaker but always cAMP-dependent protein kinase A (PKA) [7].present, suggesting that this effect was not only due to intracel-
These two signaling pathways interact in many celllular Ca2 release but also to extracellular Ca2 influx. Further-
more, the fact that the forskolin-induced potentiation of the types. However, these interactions can lead to conflicting
[Ca2]i response to Ang III was blocked by 10 mol/L H-89, results according to the biological systems studied and
a specific protein kinase A (PKA) inhibitor, indicated that this the different experimental procedures used. For in-
effect occurred via activation of PKA. Finally, the potentiation
stance, in bovine adrenal glomerulosa cells, interactionsof the [Ca2]i response to Ang III also was observed following
between the cAMP and PLC pathways lead to an en-pretreatment with 100mol/L CTP-cAMP or 107 mol/L AVP.
Conclusions. In CTAL, there is a positive crosstalk between hanced production of inositol phosphates (InsPs) [8, 9].
the adenylyl cyclase and phosphoinositide pathways mediated A potentiation by cAMP of the actions of Ca2-mobiliz-
by V2- and AT1A-R, respectively, through activation of PKA. ing hormones also has been shown in guinea pig hepato-
cytes [10]. In canine cultured tracheal smooth muscle
cells, long-term (4 hours) treatment with forskolin,
Ca2 and cyclic adenosine 3,5-monophosphate which stimulates AC or dibutyryl cAMP, an analog of
(cAMP) are two intracellular second messengers that cAMP, potentiates bradykinin-induced InsPs accumula-
play important roles in the regulation of cortical thick tion and Ca2 mobilization [11]. In contrast, in the same
ascending limb (CTAL) functions. Our earlier report on cells, short-term (2 hours) treatment with forskolin or
dibutyryl cAMP attenuates phosphoinositide (PI) hydro-
lysis and reduces Ca2 mobilization [12]. Also, pretreat-Key words: AT1A-receptor, V2-receptor, intracellular Ca2, cyclic AMP
accumulation, cortical TAL. ment of rat or bovine adrenal glomerulosa cells with
adrenocorticotropin or cholera toxin, which stimulatesReceived for publication October 8, 2001
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have been reported. As an example, treatment with Ang CTAL (0.2 to 0.3 mm) was transferred individually onto
a thin glass microscope coverslip in 1 L basal mediumII of Chinese Hamster Ovary (CHO) cells, expressing
both AT1A and V2 receptors, resulted in an increase of containing 2 mmol/L CaCl2 and 1% agarose (type IX).
Then, the agarose was jellied by cooling the slide forintracellular Ca2 mobilization that led to an enhanced
accumulation of cAMP through activation of V2 recep- two minutes on ice. The CTAL segments embedded in
agarose, were loaded with 5 mol/L Fura-2 AM at roomtors by AVP [16].
Despite numerous studies demonstrating such modu- temperature for a time that varied from 60 to 90 minutes.
For fluorescence measurements, each CTAL was placedlatory effects of cAMP on PI/Ca2 signaling, little infor-
mation is available to define whether similar regulations on the stage of an inverted microscope and was continu-
ously superfused at a rate of 0.8 mL/min at 37C withoccur in the kidney and more precisely in the CTAL. The
present study was undertaken to analyze the interactions basal medium (2 mmol/L CaCl2), which could be re-
placed at any time by the solutions to be tested. In allbetween cAMP and Ang II- and Ang III-stimulated Ca2
responses in CTAL, using forskolin or AVP pretreat- experiments, applications of Ang II and Ang III lasted
five minutes. For experiments performed in the absencement to activate the cAMP-dependent pathway. In the
present study, we found that the Ang II- or Ang III- of external Ca2, CTAL were superfused in Ca2-free
medium two minutes before adding Ang II or Ang III.induced [Ca2]i mobilization was potentiated by a pre-
stimulation with AVP leading to cyclic AMP accumula- When dimethyl sulfoxide was used for dissolving some
agents such as forskolin or H-89, we checked that it didtion. This potentiation of Ang II/Ang III effects by AVP
likely occurred through a cAMP-dependent PKA not affect Ang II- or Ang III-induced [Ca2]i responses
by using it alone at a similar concentration. The Fura-2pathway.
loaded CTAL was alternately excited at wavelengths of
340 (S) and 380 nm (L), every 4 seconds. The fluores-
METHODS
cence intensity emitted at 510 nm was recorded from a
Animals selected area delimited by an adjustable window dia-
phragm. [Ca2]i was calculated using the equation ofAll animal procedures were conducted in agreement
with our institutional guidelines for the care and use of Grynkiewicz, Poenie and Tsein [19]:
laboratory animals. Male Sprague-Dawley rats, weighing
[Ca2]i 	 Kd [(R  Rmin)/(Rmax  R)] (Lmax/Lmin) (Eq. 1)130 to 180 g, (Iffa Credo and Charles River Breeding
Laboratories, L’Arbresle, France) were used. They were where the dissociation constant, Kd 	 224 nmol/L, R 	
S/L, and Lmax, Lmin, Rmin and Rmax are L and R values atfed with normal standard diet (UAR A03, Epinay sur
Orge, France) and offered water ad libitum. 0 (min) and saturating concentrations of Ca2 (max).
Lmax, Lmin, Rmin and Rmax were determined by external
Microdissection of nephron segments calibration as previously described in [18].
The Ca2 response was evaluated either by the magni-Rats were anesthetized by IP injection of pentobarbi-
tal (6 mg/100 g body weight). The left kidney was pre- tude of the response (
[Ca2]i) given by the difference
between the peak and basal concentration (in nmol/L)pared for nephron microdissection by infusion of 5 mL
of basal medium (in mmol/L: NaCl 137, KCl 5, MgSO4 or by the integral of the Ca2 signal (in nmol · sec/L).
The integral of the Ca2 signal was calculated as t0t10.8, Na2HPO4 0.33, KH2PO4 0.44, MgCl2 1, CaCl2 1,
HEPES 20, glucose 5, lactate 5, acetate 10, pyruvate 1, [Ca2]i · dt, where t0 is the time at the start of [Ca2]i
increment and t1 is the time when the signal returns toglutamine 2, aspartate 0.3) containing 0.3% collagenase
(Serva, Heidelberg, Germany), through a catheter baseline value.
All the results are mean values of replicate samplesplaced in aorta just below the left renal artery, as pre-
viously described [17]. The kidney was then removed and SEM. Unless otherwise specified, statistical differences
were assessed by using the Student t test for unpairedsliced along the cortico-medullary axis. Small pyramids
were cut and incubated in 0.1% collagenase solution in data. EC50 was estimated by fitting the data to a non-
linear regression model using commercially availablebasal medium bubbled with filtered air, at 30C for 15
minutes. Single pieces of CTAL were isolated from the software (GraphPad Prism 2.0, San Diego, CA, USA).
cortex by freehand microdissection, in basal medium
without collagenase at 4C under stereomicroscopic ob-
RESULTS
servation according to precise anatomical and morpho-
Effect of forskolin on Ang II- and Ang III-inducedlogical criteria [17].
Ca2 mobilization
Measurements of intracellular Ca2 concentration When CTAL segments were stimulated with 107 mol/L
Ang II or Ang III for 5 minutes after a 10-minute prein-Intracellular Ca2 concentration ([Ca2]i) was measured
as previously described [18]. After microdissection, each cubation with 5 mol/L forskolin, significant enhance-
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ment of agonist-induced [Ca2]i increases were observed concentration used. At the highest concentrations of Ang
(Fig. 1). The mean  SEM percent increases were 42  III (3 107 to 105 mol/L), the maximal [Ca2]i response
16% (N 	 7) for Ang II (Fig 1A) and 50  10% (N 	 in forskolin-treated CTAL (460 14 nmol/L) was almost
10) for Ang III (Fig. 1B) compared with responses of twofold greater than that obtained in controls (266  5
untreated CTAL. Note that the superfusion of forskolin nmol/L, P  0.001). In contrast, pretreatment by for-
alone at the same concentration did not modify the basal skolin did not alter the half maximal Ca2 response to
level of [Ca2]i (Fig. 1, a2 and b2). A 10-minute preincu- Ang III (16.9  5.6 nmol/L vs. 12.5  3.4 nmol/L).
bation with either 5 or 10 mol/L forskolin induced a The integral of Ca2 signal calculated by area under
similar potentiation of the [Ca2]i responses induced by curve was also significantly higher in the presence of
3  107 mol/L Ang III (control 249  19 vs. 405  44 forskolin for all Ang III concentrations used (Table 1).
and 436  65 nmol/L, P  0.05 for 5 and 10 mol/L for- Note that values decreased from 106 mol/L Ang III in
skolin-treated CTAL, respectively). control and forskolin-treated CTAL, due to the desensi-
tization process that occurred for high doses of agonist.
Effects of type 1 receptor antagonist losartan on However, this desensitization phenomenon modified
Ang II/Ang III-induced Ca2 responses only the integral of Ca2 signal but not the magnitude
Figure 2 shows that potentiation of [Ca2]i responses of the Ca2 response as shown on the Figure 3.
to 107 mol/L Ang II induced by pretreatment with 1
mol/L forskolin were totally abolished by 1 mol/L Involvement of protein kinase A in the
losartan. Similar results were obtained with Ang III (data potentiation of [Ca2]i response to Ang III by
not shown). In these experiments we checked that the pre-exposure to forskolin
total abolition of the Ca2 responses induced by Ang II To investigate the involvement of PKA in the potenti-
or Ang III was not due to a loss of cell viability, because a ation of the Ca2 response to Ang III by forskolin pre-
subsequent application of 107 mol/L bradykinin induced treatment, we used the PKA inhibitor, H-89. The su-
significant Ca2 responses (711  89 nmol/L, N 	 5). perfusion of 10 mol/L H-89 together with 5 mol/L
forskolin for 10 minutes totally suppressed the potentia-Time-dependence of the effects of forskolin
tion of the Ca2 response to 107 mol/L Ang III (Table 2).pretreatment on potentiation of [Ca2]i
Superfusion of H-89 alone, at the same concentration,responses to Ang III
did not significantly affect the Ca2 responses induced
Cortical thick ascending limb segments were preincu- by Ang III, as compared to the control response obtained
bated in the presence of 5 mol/L forskolin for 0, 5, 10
with Ang III alone (Table 2). In addition, we checked
and 15 minutes and then superfused with 107 mol/L Ang
that 10-minute pretreatment with H-89 did not signifi-III for 5 minutes. As compared to the control values
cantly modify the Ca2 basal levels as compared to un-(226  18 nmol/L; N 	 16), significant potentiation of
treated segments: 80  7 nmol/L (N 	 7) versus 68 the Ca2 responses occurred at 5 and 10 minutes pretreat-
13 nmol/L (N 	 16), respectively.ment with forskolin [332  31 (N 	 7), P  0.01 and
338  22 nmol/L (N 	 10), P  0.01, respectively], but Enhancement of the [Ca2]i response to
not at 0 and 15 minutes [229  24 (N 	 8) and 256  Ang III in CTAL by pre-exposure to
20 nmol/L (N 	 6), respectively]. According to these forskolin in a Ca2-free medium
results, the duration of preincubation with forskolin and
To determine the involvement of release of intracellu-other agents tested equal to 10 minutes was chosen for
lar Ca2 and/or Ca2 influx in the forskolin-induced po-all experiments.
tentiation of the Ca2 responses elicited by Ang III, we
performed experiments in a Ca2-free medium in theDose-response curves to Ang III in control and
absence or in the presence of 5 mol/L forskolin for 10forskolin-treated CTAL
minutes and then exposed CTAL to various concentra-Since superfusion of forskolin produced similar en-
tions of Ang III. Figure 4 clearly indicated that in thehancement of Ang II- or Ang III-induced [Ca2]i re-
absence of external Ca2, forskolin-pretreatment sig-sponses in CTAL, dose-response curves were performed
nificantly increased the [Ca2]i responses to 108, 107with Ang III. Accordingly, CTAL segments were prein-
and 106 mol/L Ang III, suggesting that this phenomenoncubated in the absence or in the presence of 5 mol/L
might be due to an increase in PLC activity. These obser-forskolin for ten minutes and then superfused with vari-
vations also were corroborated by the increases observedous concentrations of Ang III for 5 minutes. The data
on the integral of Ca2 signals induced by Ang III afterin Figure 3 show the relationship between Ang III con-
pretreatment with forskolin, in the absence or presencecentrations and [Ca2]i changes in CTAL pretreated with
of external Ca2 (Table 3). However, these increasesforskolin. Forskolin pretreatment significantly increased
the [Ca2]i responses elicited by Ang III, whatever the were lower that those induced by forskolin in the pres-
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Fig. 1. Representative recordings of intracellular Ca2 levels elicited by 107 mol/L Ang II (A) or 107 mol/L Ang III (B) in the cortical thick
ascending limb (CTAL) calculated from (N) individual determinations after 10 minutes of pretreatment with either vehicle alone (a1, b1) or 5
mol/L forskolin (a2, b2). Each bar represents the mean data (SEM): panel a3, () Ang II and ( ); Ang II  forskolin; panel b3, () Ang
III and () Ang III  forskolin. 
[Ca2]i is the variation in intracellular Ca2 concentration expressed as a peak increase in [Ca2]i above basal
values. *P  0.05, **P  0.001.
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Fig. 2. Representative recording of intracel-
lular Ca2 levels elicited by 107 mol/L Ang II
in the CTAL after 10 minutes of pretreatment
with 5mol/L forskolin and 1mol/L losartan
followed by a subsequent application of 107
mol/L bradykinin also performed in the pres-
ence of losartan.
Table 2. Effect of H-89 on Ang III-induced Ca2 mobilization
Conditions [Ca2]i increases nmol/L
Ang III 22125 (5)
Forskolin  Ang III 33822 (10)a
Forskolin  H-89  Ang III 17727 (7)b
H-89  Ang III 24433 (6)b
CTAL were pretreated for 10 min with either 5 mol/L forskolin alone,
forskolin plus 10 mol/L H-89 or H-89 alone and then exposed to 107 mol/L
Ang III. The results are expressed as the mean SEM. The numbers in parenthe-
ses indicate the number of separate measurements.
a P  0.01 and b not significant as compared to untreated CTAL, Ang III
(vehicle)
ence of 2 mmol/L Ca2, indicating that forskolin en-
hanced the Ca2 influx produced by Ang III.
Effect of AVP on Ang III-induced Ca2 mobilization
Figure 5 shows that the 10 minute preincubation withFig. 3. Effects of forskolin treatment on dose-response curve of Ang
III-induced Ca2 mobilization. CTAL were superfused either in the pres- 107mol/L AVP caused a significant enhancement of the
ence of vehicle alone () or 5 mol/L forskolin for 10 min () and then Ca2 response induced by Ang III compared with the
exposed to various concentrations of Ang III. Each point represents the
responses of untreated CTAL (58  11%, N 	 9). Inmean calculated from 5 to 16 individual determinations. 
[Ca2]i is
the variation in intracellular Ca2 concentration expressed as a peak contrast to forskolin, the superfusion of AVP alone pro-
increase in [Ca2]i above basal values. *P  0.05, **P  0.01 when duced low increases in [Ca2]i (23  5 nmol/L, N 	 8).compared to control curve.
Considering the weak amplitude of the [Ca2]i responses
to AVP, we have calculated the theoretical expected
amplitude of Ca2 responses in the presence of both
hormones (calculated additivity). The results indicateTable 1. Intracellular Ca2 measurements in response to different
that increases of [Ca2]i responses induced by Ang IIIdoses of Ang III following forskolin pretreatment in the CTAL
after preincubation with AVP were significantly higher
Integrals of the Ca2 signal nmol · sec/L
that theoretical [Ca2]i responses obtained by adding the
Ang III mol/L Control Forskolin-treated separated effects of 107 mol/L AVP and 107 mol/L Ang
109 109211110 (6) 169242307 (7)a III (43  10%, N 	 9).
108 151221999 (14) 273472144 (14)b
When CTAL segments were stimulated by 107 mol/L107 192421255 (16) 341503245 (9)b
106 106211773 (5) 221971241 (8)b Ang III after preincubation with 100 mol/L CTP-cyclic
105 7796741 (7) 171823280 (8)a AMP [8-(4-chlorophenylthio)-adenosine 3,5-cyclic mo-
Cortical thick ascending limbs (CTALs) were pretreated for 10 minutes with nophosphate; a cell-permeable cAMP analog], an en-
vehicle (Control) or 5 mol/L forskolin (Forskolin-treated) and then superfused
hancement of the agonist-induced [Ca2]i increases alsowith different concentrations of angiotensin III (Ang III). The results are ex-
pressed as the mean  SEM. The numbers in parentheses indicate the number was observed (control 201  4 vs. CTP cAMP-treated
of separate measurements.
a P  0.05, b P  0.001 as compared to Control 334  1 nmol/L, P  0.01).
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Fig. 4. Effects of forskolin treatment on vari-
ous doses of Ang III-induced Ca2 mobiliza-
tion in Ca2-free medium. CTAL were super-
fused in the absence of external Ca2 either
in the presence of vehicle alone, control ()
or 5 mol/L forskolin for 10 min ( ) and then
exposed to three different concentrations of
Ang III. Each bar represents the mean calcu-
lated from (N) individual determinations and
the data are expressed as the mean  SEM.

[Ca2]i is the variation in intracellular Ca2
concentration expressed as a peak increase in
[Ca2]i above basal values. *P  0.05, **P 
0.01 when compared to control.
Table 3. Potentiation of [Ca2]i responses in forskolin-treated CTAL in presence or in absence of external calcium
Increases of integrals of the Ca2 signal nmol · sec/L
Conditions In the presence of external calcium In the absence of external calcium
ForskolinAng III (108 mol/L) 122252144 (14) 4854618 (5)a
ForskolinAng III (107 mol/L) 149083245 (9) 44831007 (6)b
ForskolinAng III (106 mol/L) 115761241 (8) 68431064 (4)c
CTAL were pretreated for 10 min with 5 mol/L forskolin and then exposed to three different concentrations of Ang III, in the presence (2 mmol/L) or absence
of external calcium. In these two experimental conditions, increases of areas under curve were calculated as the difference between [Ca2]i responses elicited by Ang
III (at three different doses) after pretreatment with forskolin to those elicited by Ang III alone (vehicle). These increases of areas under curve were issued from
data of Table 1 and Figure 4, respectively. The results are expressed as the mean  SEM. The numbers in parentheses indicate the number of separate measurements.
a 0.1  P  0.05, b P  0.01, c P  0.001 as compared with values obtained in the presence of external calcium
DISCUSSION of this effect is in good agreement with data obtained in
FRTL-5 thyroid cells showing that a phosphodiesteraseIn the last years, the importance of intracellular signal-
(PDE) isoenzyme, a member of the PDE4 family, ising networks in regulating cellular responses has been
implicated in the short-term feedback regulation ofinvestigated thoroughly. In this study, we demonstrate
cAMP [20]. Furthermore, a muscle-selective A-kinasefor the first time, to our knowledge, that intracellular
anchoring protein (mAKAP) recently was shown to beCa2 responses in the CTAL induced by Ang II/Ang
essential in the heart for the assembly of a PKA/PDEIII and mediated by the AT1 receptor were potentiated
negative feedback loop [21]. Thus, despite the constanteither by stimulating AC by forskolin, or in the presence
presence of forskolin in the incubation medium, the lim-of an analog of cAMP or AVP. This potentiation was
ited potentiation of the [Ca2]i response to Ang III in-not only due to an increase of intracellular Ca2 release,
duced by forskolin only observed for 5 and 10 minutesbut also to an increase of extracellular Ca2 influx. Since
also could result from a feedback regulation in order tothe forskolin-induced potentiation of the [Ca2]i re-
prevent a too prolonged cellular stimulus.sponses to Ang II/Ang III was blocked by H-89, this
Analysis of dose-response curves to Ang III showedindicated that this effect occurred via activation of PKA.
that forskolin pretreatment significantly increased theThese data provide evidence of the existence of a positive
magnitude of the [Ca2]i responses induced by Ang III,crosstalk between the AC and PI pathways via V2-R and
whatever the concentration used (Fig. 3). In contrast,AT1A-R, and point out the physiological consequences
when considering the integral of the Ca2 signal, weof such an interaction in the CTAL.
observed that values decreased at concentrations higherThe enhancement of the Ca2 response to Ang III
than 106 mol/L Ang III in the absence or in the presenceafter exposure to forskolin was time-dependent. This
of forskolin (Table 1). This observation was probablypotentiation was transient, observed at 5 and 10 minutes
due to the fact that Ang III initiated a protein kinaseof preincubation with forskolin and decreased to the
baseline level at 15 minutes of preincubation. The kinetic C-mediated negative feedback loop that rapidly termi-
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Fig. 5. Representative recordings of intracellular Ca2 levels elicited by 107 mol/L Ang III in the CTAL after 10 minutes of pretreatment with
either vehicle alone (A) or 107 mol/L AVP (B). The mean  SEM values are shown in panel C for AVP ( ), Ang III (), and the theoretical
( ) and experimental () values for AVP  Ang III. Each bar represents the mean calculated value from (N) individual determinations. 
[Ca2]i
is the variation in intracellular Ca2 concentration expressed as a peak increase in [Ca2]i above basal values. a Statistically different from the

[Ca2]i obtained with either Ang III or AVP  Ang III (theoretical and experimental values). b Statistically different from the 
[Ca2]i obtained
with AVP  Ang III (experimental values). c Statistically different from experimental values (one-way analysis of variance on weighted means
followed by LSD Fisher’s t test). a, b and c P  0.001.
nated the Ang III responses [22]. Figure 3 shows that crosstalk between the [Ca2]i and cAMP signal transduc-
tion cascades. According to the second hypothesis, PKAthe concentration of Ang III required to produce half-
maximal stimulation was not significantly changed by may act directly on the InsP3 receptor since (a) PKA was
found in membrane fractions enriched with the InsP3forskolin, indicating that cAMP-mediated potentiation
was not due to a change in the affinity of the AT1A receptor [24] and (b) this receptor possesses phosphory-
lation sites for serine-threonine protein kinases, suggest-receptors for Ang II/Ang III. This suggested that the
cyclic AMP site action could be located downstream to ing that PKA can phosphorylate the InsP3 receptor [10].
The [Ca2]i response elicited by Ang II is characterizedthe AT1A receptor, possibly at the level of PKA since
cAMP activates PKA, which in turn phosphorylates in- by two distinct phases in the CTAL: a transient rise
corresponding to the release of Ca2 from intracellulartracellular proteins involved in various cell functions.
Our results showed clearly that the potentiation of the stores and a more sustained increase due to the entry of
Ca2 across the plasma membrane [2]. In the presentCa2 responses induced by Ang III after exposure to
forskolin was mediated by the cAMP-PKA pathway, work, the comparison of the data obtained with and
without extracellular Ca2 showed that an accumulationsince preincubation with H-89 abolished this enhance-
ment. Several hypotheses arise from this observation: in cAMP levels can potentiate both intracellular Ca2
mobilization and Ca2 influx. Both Ca2 release and Ca2PKA could interact (1) directly on the AT1A receptor
itself and/or (2) indirectly on other molecules involved entry can regulate specific cellular functions. For in-
stance, in cultured proximal tubule cells, inhibition ofin the InsP3 pathway. Concerning the first hypothesis,
since the AT1A receptor possesses two consensus se- PLC by exogenous cAMP completely blocked Ang II-
dependent sodium transport [25]. In human adrenalquences for PKA-mediated phosphorylation [23], it can-
not be excluded that the AT1A receptor may be a site of glomerulosa cells, a positive feedback loop between ade-
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Fig. 6. Model for AVP or forskolin-potentiates Ca2 responses induced by Ang II/Ang III in CTAL. Dashed lines denote the putative pathways.
Abbreviations are DAG, diacylglycerol; PKC, protein kinase C; InsP3-R, InsP3 receptor/channel; PDE, phosphodiesterase.
nylyl cyclase-PKA-Ca2 channels ensures a slow but sus- NaCl is reabsorbed via the Na-K-2Cl cotransport
driven by the basolateral Na,K-ATPase. Many hor-tained [Ca2]i increase that is responsible for sustained
cAMP production and aldosterone secretion [26]. As mones have been shown to increase reabsorption of so-
dium and chloride in the thick ascending limb, such aspreviously described by Scharenberg and Kinet in non-
excitable cells [27], at the initial step of the Ca2 signal parathyroid hormone, calcitonin, glucagon, adrenaline
and, more interestingly as part of this study, AVPelicited by Ang II, InsP3 production causes the release
of Ca2 from endoplasmic reticulum stores. It is well [28, 29]. However, with regards to Ang II/Ang III, most
studies have focused on the proximal tubular actions ofknown, however, that intracellular Ca2 stores are lim-
ited and able to produce only a transient Ca2 signal; Ang II, and there is much less information on the effects
of this peptide on the loop of Henle. In a preliminaryconsequently, an extracellular Ca2 influx is required for
sustained Ca2 signals [27]. In our experimental condi- work, we showed that Ang II/Ang III could participate
to the sodium reabsorption in the CTAL since stimula-tions, the involvement of Ca2 influx in response to an
increase of cAMP level in the CTAL was probably de- tion of AT1A receptors by Ang II/Ang III in this segment
induced regulation of both Na,K-ATPase and Na-pendent on the primary event that occurred after stimu-
lation by Ang II/Ang III, which was the Ca2 release K-2Cl cotransport via a signaling pathway involving
the PKC (abstract; Hus-Citharel et al, J Am Soc Nephrolfrom intracellular stores. Thus, in our conditions of posi-
tive crosstalk between cAMP and Ca2 in CTAL, the 11:422A, 2000). In addition, the study of Schlatter and
Greger found that the basolateral chloride conductanceincrease in Ca2 influx could play an additional role that
could be particularly important in sustaining Ca2 signals is augmented by cAMP-dependent phosphorylation, and
that this leads to an activation of the Na-K-2Cl co-necessary for leading to the final physiological response.
Finally, we also observed that the potentiation of the transport and the Na,K-ATPase [30]. Taking account
of the fact that Ang II/Ang III by increasing tubular[Ca2]i responses to Ang III occurred not only following
a pretreatment with forskolin, but also in presence of NaCl reabsorption at multiple sites provides a powerful
mechanism to protect against volume depletion and lowAVP, which is known to stimulate the adenylyl cyclase
pathway in the CTAL via the V2 receptors. These results blood pressure, we can speculate that the positive cross-
talk that we observed between AT1A and V2 receptorsin the CTAL showed the presence of a positive crosstalk
between the adenylyl cyclase and the phosphoinositide in the CTAL could constitute an additional synergetic
mechanism, allowing the common biological actions ofpathways that can occur following activation of the V2 and
AT1A receptors, respectively, through activation of PKA. AngII/AngIII and AVP to be potentiated in this seg-
ment.In the thick ascending limb, 20 to 30% of the filtered
Hus-Citharel et al: cAMP, [Ca2]i and Ang III2004
5. Firsov D, Mandon B, Morel A, et al: Molecular analysis of vaso-Conversely, as already mentioned earlier in CHO
pressin receptors in the rat nephron. Evidence for alternative splic-cells, activation of the AT1A receptor by Ang II potenti- ing of the V2 receptor. Pflu¨gers Arch 429:79–89, 1994
ates the V2 receptor through activation of protein kinase 6. Ohnishi J, Ishido M, Shibata T, et al: The rat angiotensin II AT1A
receptor couples with three different signal transduction pathways.C in the presence of intracellular Ca2 at a step located
Biochem Biophys Res Commun 186:1094–1101, 1992between the receptor and the adenylyl cyclase [16]. In 7. Jard S: Vasopressin isoreceptors in mammals: Relation to cyclic
fact, crosstalk between Ca2 and cAMP also has been AMP-dependent and cyclic AMP-independent mechanisms, in
Current Topics in Membrane and Transport (vol 18), edited byreported in numerous other cell types. As example, in
Kleinzeller A, Martin BR, New York, Academic Press, 1983,bovine adrenal glomerulosa cells stimulation by Ang II
pp 255–285
potentiates the ACTH-induced cAMP formation by a 8. Baukal A, Hunyady L, Balla T, et al: Modulation of agonist-
capacitive Ca2 influx stimulated upon Ca2 release from induced inositol phosphate metabolism by cyclic adenosine 3,5-
monophosphate in adrenal glomerulosa cells. Molec Endocrinolintracellular stores by InsP3 [31]. These later observa-
4:1712–1719, 1990tions strongly suggested the existence of an adaptive
9. Ouali R, Langlois D, Saez J, Begeot M: Opposite effects of
crosstalk phenomenon that is cell type-dependent. angiotensin-II and corticotropin on bovine adrenocortical cell ste-
roidogenic responsiveness. Mol Cell Endocrinol 81:43–52, 1991Together these data led us to propose a working hy-
10. Burgess G, Bird GSJ, Obie J, Putney JJ: The mechanism forpothesis for mechanisms that induce potentiation by
synergism between phospholipase C- and adenylcyclase-linkedcAMP of the Ca2 responses induced by Ang II/Ang III hormones in liver. J Biol Chem 266:4772–4781, 1991
in the CTAL (Fig. 6). In this model, we hypothesize that 11. Yang C, Hsia H, Luo S, et al: The effect of cyclic AMP elevating
agents on bradykinin- and carbachol-induced signal transductiona first stimulation of AC by AVP or forskolin leads to
in canine cultured tracheal smooth muscle cells. Br J Pharmacolactivation of PKA, stimulation of InsP3 receptor or AT1A 112:781–788, 1994
receptor, and subsequently increases intracellular Ca2 12. Luo S, Chiu C, Tsao H, et al: Effect of forskolin on bradykinin-
induced calcium mobilization in cultured canine tracheal smoothmobilization induced by Ang II/Ang III as a result of a
muscle cells. Cell Signal 9:159–167, 1997synergism between PKA and PLC. However, further
13. Guillon G, Gallo-Payet N, Balestre MN, Lombard C: Cholera
studies are needed to confirm this putative model. toxin and corticotropin modulation of inositol phosphate accumu-
In conclusion, the present study demonstrates a posi- lation induced by vasopressin and angiotensin II rat glomerulosa
cells. Biochem J 253:765–775, 1988tive interaction between AC and PLC pathways via
14. Woodcock E: Adrenocorticotropic hormone inhibits angiotensinPKA, which leads to the potentiation of [Ca2]i responses II-stimulated inositol phosphate accumulation in rat adrenal glom-
induced by Ang II/Ang III. The potentiation of the Ca2 erulosa cells. Mol Cell Endocrinol 63:247–253, 1989
15. Yoshida A, Nishikawa T, Tamura Y, Yoshida S: ACTH-inducedresponse observed in the CTAL after exposure to AVP
inhibition of the action of angiotensin II in bovine zona glomeru-suggests that in vivo Ang II/Ang III and AVP might
losa cells. J Biol Chem 266:4288–4294, 1991have synergetic interactions to modulate the physiologi- 16. Klinger C, Ancellin N, Barrault M, et al: Angiotensin II potenti-
cal activity of this nephron segment, depending on the ates vasopressin-dependent cAMP accumulation in CHO trans-
fected cells. Mechanisms of cross-talk between AT1A and V2 recep-duration of the prestimulation with agonist-induced
tors. Cell Signal 10:65–74, 1998cAMP accumulation.
17. Le Bouffant F, Hus-Citharel A, Morel F: Metabolic CO2 pro-
duction by isolated single pieces of rat distal nephron segments.
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